Bevacizumab plus interferon alpha in patients with metastatic renal cell carcinoma.
Twardowski
Przemyslaw
P
Division of Medical Oncology and Experimental Therapeutics, City of Hope Cancer Center, Duarte, CA 91010, USA.
Figlin
Robert A
RA